The wage gap fell nearly 14% in 2018 as female doctors earned $90,490 less than the average male doctor in 2018, down from $105,000 in 2017, but significant disparities still exist in individual markets.

Anthony Tersigni, who will have led Ascension for more than 15 years when he retires, will continue to serve on the executive committee of Ascension's healthcare investment fund and help guide the 151-hospital system on a consulting basis.

HCA Healthcare allegedly submitted false claims for services delivered at its rehabilitation hospitals to secure higher reimbursement rates, a former HCA occupational therapist claims.

The antitrust lawsuit alleged that not-for-profit health system CHI Franciscan's affiliation with two Kitsap County physician groups raised prices and decreased competition.

New payment programs that include both upside and downside risk seem perpetually stuck in a state of delay, researchers said.

Massachusetts' second-largest health insurer aims to grow its Medicare Advantage business both organically and through mergers and acquisitions, CEO Michael Carson said.

Occupancy at rural skilled-nursing facilities has declined by about 7 percentage points since 2012, which makes them more vulnerable to closure or consolidation, according to new data.

Dr. Ranga Krishnan, dean of Rush Medical College, and Dr. Omar Lateef, Rush's chief medical officer, will split Goodman's role after his 17-year tenure at the Chicago system ends.

Prices increased 13% as utilization dropped by 17% from 2012 to 2016, according to a new iteration of the Health Care Cost Institute's analysis. Metro areas with higher prices tended to have lower use.

Dr. Scott Gottlieb made headway on a number of fronts at the FDA, including increasing the rate of approval of generic drugs and taking on big tobacco.

A well-defined split-CEO governing model, described as a bridge to complete a merger and appease both parties, is typically most successful as a short-term solution, experts say.

Patients are paying more for drugs through their premiums, pharmacy revenue has more than doubled and pharmacy benefit managers have passed a growing share of manufacturer rebates to health plans.

In a congressional hearing, experts recommended new policies and legislation aimed at restoring competition in lopsided pharmaceutical and provider markets.

Medical, pharmaceutical and administrative cost restructuring as well as better risk-adjustment coding helped the health plan post $71 million of operating income in 2018.

Beaumont Health’s new venture represents a growing trend of health systems building out ancillary businesses as they try to adapt to a less profitable operating environment.